amlodipine has been researched along with thapsigargin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marche, P; Stepien, O | 1 |
| Florea, S; Raicu, M | 1 |
| Ishibashi, T; Nishio, M; Yoshida, J | 1 |
3 other study(ies) available for amlodipine and thapsigargin
| Article | Year |
|---|---|
Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells.
Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Transporting ATPases; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Intracellular Fluid; Isradipine; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Rats, Inbred WKY; Sarcoplasmic Reticulum; Signal Transduction; Thapsigargin; Thrombin; Verapamil | 2000 |
Deleterious effects of nifedipine on smooth muscle cells implies alterations of intracellular calcium signaling.
Topics: Amlodipine; Aorta; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Transporting ATPases; Cells, Cultured; Endoplasmic Reticulum; Enzyme Inhibitors; Felodipine; Genistein; Humans; Muscle, Smooth, Vascular; Nifedipine; Protein-Tyrosine Kinases; Thapsigargin | 2001 |
Antitumor effects of amlodipine, a Ca2+ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo.
Topics: Amlodipine; Animals; Antineoplastic Agents; Calcium; Calcium Channel Blockers; Carcinoma, Squamous Cell; Enzyme Inhibitors; Fluorometry; Humans; Male; Mice; Mice, Nude; Nucleic Acid Synthesis Inhibitors; Thapsigargin; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Type C Phospholipases; Uridine Triphosphate | 2004 |